The relevance of LRP10 for APP processing and its potential contribution to the pathogenesis of AD is supported by the observation that LRP10 is expressed at much lower levels in the brains of AD patients, which would result in higher Aβ levels in these patients. Here, APP is linked to Alzheimer disease.